US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Weight Loss Drugs

1,175.71

-20.7638-1.74%

Number of Gainers:1

Number of Losers:6

Number of Flat:- -

PE:- -

High:1,211.92

Open:1,195.10

Low:1,174.59

Close:1,196.47

Loading ...

Viking Therapeutics Inc : Truist Securities Cuts Target Price to $75 From $95

THOMSON REUTERS

3 Dividend Stocks to Buy and Hold for the Next Decade

Down 36%, Is Moderna a Buy on the Dip?

Pfizer's Potential Invasive Bladder Cancer Treatment Meets Primary Endpoint

MT Newswires Live

Novo Nordisk's obesity drug Wegovy debuts in Thailand

Eli Lily Shares Down 1.4% Premarket After HSBC Double Downgrades Rating to 'Reduce'

THOMSON REUTERS

Eli Lilly & Co : HSBC Cuts to Reduce From Buy

THOMSON REUTERS

Pfizer announces Phase 3 CREST trial met primary endpoint of EFS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK4599/news?page=10"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4599","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","market":"US","secType":"PLATE","nameCN":"Weight Loss Drugs","latestPrice":1175.7089,"timestamp":1746820799999,"preClose":1196.4727,"halted":0,"volume":65719852,"delay":0,"changeRate":-0.017354,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":-20.763794,"latestTime":"05-09 16:00:00 EDT","open":1195.0991,"high":1211.9174,"low":1174.5859,"amount":5821015703.3311,"amplitude":0.031201,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1747056600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":9.288045,"peRate":31.06629,"turnoverRate":0.006213,"increases":1,"decrements":6,"flats":0,"marketCap":1262750061408,"floatMarketCap":1178055790176},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","high":1211.9174,"amplitude":0.031201,"preClose":1196.4727,"low":1174.5859,"pbRate":"9.288045","latestPrice":1175.7089,"volume":65719852,"delay":0,"open":1195.0991,"prevYearClose":1305.0607,"prevWeekClose":1175.7089,"prevMonthClose":1353.2255,"prevQuarterClose":1314.3724,"fiveDayClose":1289.8245,"twentyDayClose":1150.8268,"sixtyDayClose":1395.824,"secType":"PLATE","market":"US","turnoverRate":0.006213,"peRate":31.06629,"marketCap":1262750061408,"floatMarketCap":1178055790176,"timestamp":1746820799999,"nameCN":"Weight Loss Drugs"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4599\",,,,undefined,":{"bkCode":"BK4599","up":1,"down":6,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4599\",pageSize:20,pageCount:10,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2530403257","title":"Viking Therapeutics Inc : Truist Securities Cuts Target Price to $75 From $95","url":"https://stock-news.laohu8.com/highlight/detail?id=2530403257","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530403257?lang=en_us&edition=fundamental","pubTime":"2025-04-28 20:01","pubTimestamp":1745841670,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250428:nFWN3R61ZI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4599","VKTX","BK4585","BK4588"],"gpt_icon":0},{"id":"2530754408","title":"3 Dividend Stocks to Buy and Hold for the Next Decade","url":"https://stock-news.laohu8.com/highlight/detail?id=2530754408","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530754408?lang=en_us&edition=fundamental","pubTime":"2025-04-28 19:47","pubTimestamp":1745840820,"startTime":"0","endTime":"0","summary":"Abbott Laboratories is a diversified dividend stock with a growing payout.AbbVie is a reliable dividend payer to hold for the long term.Pfizer offers an ultra-high dividend yield and a growth story that's better than it might appear at first glance.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/04/28/3-dividend-stocks-to-buy-and-hold-for-the-next-dec/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["LU1023059063.AUD","LU0058720904.USD","BK4533","LU0985481810.HKD","LU2089984988.USD","PFE","IE0002141913.USD","LU2112291526.USD","IE00B19Z3B42.SGD","BK4550","LU0122379950.USD","LU0321505868.SGD","BK4588","BK4082","IE00BBT3K403.USD","LU0321505439.SGD","LU0234572021.USD","SG9999001176.USD","SG9999004303.SGD","BK4585","BK4592","BK4568","IE00B4R5TH58.HKD","ABT","LU1066053197.SGD","LU1721429402.USD","LU1066051498.USD","IE00BLSP4452.SGD","IE00BLSP4239.USD","IE00BFTCPJ56.SGD","LU0868494617.USD","LU1883839398.USD","LU2133065610.SGD","BK4566","LU1894683264.USD","BK4534","IE000M9KFDE8.USD","BK4581","SG9999011175.SGD","BK4599","LU0170899867.USD","IE00B19Z3581.USD","LU0225284248.USD","IE00BJJMRZ35.SGD","LU2468319806.SGD","LU1721429741.USD","SGXZ23171101.USD","LU1691799644.USD","IE0002270589.USD","LU1894683348.USD"],"gpt_icon":1},{"id":"2530766084","title":"Down 36%, Is Moderna a Buy on the Dip?","url":"https://stock-news.laohu8.com/highlight/detail?id=2530766084","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530766084?lang=en_us&edition=fundamental","pubTime":"2025-04-28 18:21","pubTimestamp":1745835660,"startTime":"0","endTime":"0","summary":"It wasn't so long ago that the company was a major star in the biotech world.This was on the basis of one product, however, and demand for it is declining steeply.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/04/28/down-36-is-moderna-a-buy-on-the-dip/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["BK4568","LU0321505439.SGD","SG9999001176.USD","IE00BBT3K403.USD","LU0289739699.SGD","IE00B19Z3581.USD","LU0122379950.USD","BK4592","LU1894683264.USD","LU0321505868.SGD","BK4533","BK4588","LU0225771236.USD","SG9999013999.USD","SG9999002224.SGD","LU0456855351.SGD","LU1066053197.SGD","LU0306806265.USD","SG9999003800.SGD","LU0170899867.USD","BK4581","LU1894683348.USD","LU1883839398.USD","IE00B19Z3B42.SGD","IE00BLSP4452.SGD","SG9999011175.SGD","BK4585","SGXZ57979304.SGD","LU1066051498.USD","BK4007","LU0225284248.USD","IE00BLSP4239.USD","LU0058720904.USD","IE0002270589.USD","BK4599","LU0868494617.USD","LU1057294990.SGD","LU0306807586.USD","LU1023059063.AUD","SG9999001176.SGD","LU0234572021.USD","SG9999002232.USD","BK4534","LU0985481810.HKD","IE000M9KFDE8.USD","BK4550"],"gpt_icon":1},{"id":"2530242702","title":"Pfizer's Potential Invasive Bladder Cancer Treatment Meets Primary Endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2530242702","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530242702?lang=en_us&edition=fundamental","pubTime":"2025-04-28 17:52","pubTimestamp":1745833948,"startTime":"0","endTime":"0","summary":"Pfizer  said Saturday that its investigational drug sasanlimab in combination with standard of care Bacillus Calmette-Guerin as induction and maintenance therapy in patients with high-risk non-muscle invasive bladder cancer met its primary endpoint of event-free survival in a phase 3 trial.The trial showed a 32% reduction in the risk of disease-related events with the sasanlimab combination regimen as compared with the standard of care treatment alone, the pharmaceutircal giant said.The probability of being event-free at 36 months was 82.1% with sasanlimab in combination with BCG and 74.8% with BCG alone, the company said.Sasanlimab in combination with induction-only BCG failed to meet a secondary endpoint of prolongation of event-free survival compared with BCG alone as an induction and maintenance therapy, the company said.Pfizer said it has shared study data with health authorities worldwide to support potential regulatory filings.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BBT3K403.USD","LU0306807586.USD","PFE","LU1066053197.SGD","LU1894683264.USD","LU1066051498.USD","SG9999013999.USD","IE00BLSP4452.SGD","BK4568","IE000M9KFDE8.USD","BK4599","SG9999002232.USD","LU0321505439.SGD","BK4534","LU0170899867.USD","LU0321505868.SGD","LU0225771236.USD","LU1883839398.USD","LU0306806265.USD","IE0002270589.USD","SG9999001176.USD","LU0225284248.USD","BK4592","BK4007","BK4533","IE00B19Z3B42.SGD","LU1023059063.AUD","SG9999011175.SGD","LU1057294990.SGD","LU0868494617.USD","BK4588","SG9999003800.SGD","BK4585","IE00BLSP4239.USD","LU0122379950.USD","LU1894683348.USD","BK4581","BK7095","SGXZ57979304.SGD","LU0456855351.SGD","LU0234572021.USD","PFE.AU","LU0058720904.USD","LU0289739699.SGD","SG9999002224.SGD","SG9999001176.SGD","LU0985481810.HKD","BK4550","IE00B19Z3581.USD"],"gpt_icon":1},{"id":"2530426773","title":"Novo Nordisk's obesity drug Wegovy debuts in Thailand","url":"https://stock-news.laohu8.com/highlight/detail?id=2530426773","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530426773?lang=en_us&edition=fundamental","pubTime":"2025-04-28 17:01","pubTimestamp":1745830913,"startTime":"0","endTime":"0","summary":"Novo Nordisk's obesity drug Wegovy debuts in ThailandBy Panu Wongcha-um","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250428:nL4N3R60IA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2471134879.HKD","LU1712237335.SGD","LU2491050071.SGD","LU2237443549.SGD","LU0640476718.USD","BK4581","SGXZ51526630.SGD","BK4599","LU0943347566.SGD","LU0203202063.USD","LU0823416689.USD","LU1551013342.USD","LU2106854487.HKD","SG9999014914.USD","LU2264538146.SGD","LU0256863811.USD","LU0672654240.SGD","SG9999015952.SGD","LU2491049909.HKD","IE00B2B36J28.USD","LU1069344957.HKD","SG9999015986.USD","LU2461242641.AUD","LU1983299246.USD","LU1023059063.AUD","BK4007","IE0004445239.USD","LU0058720904.USD","LU2112291526.USD","IE00BJT1NW94.SGD","LU0097036916.USD","LU1623119135.USD","LU0203201768.USD","LU1868837136.USD","BK4588","LU0882574055.USD","IE00BK4W5M84.HKD","SGXZ99366536.SGD","LU2471134952.CNY","BK4534","LU0456855351.SGD","LU0198837287.USD","LU1868836591.USD","LU1127390331.HKD","LU0109391861.USD","LU2063271972.USD","SG9999015978.USD","LU1804176565.USD","LU1988902786.USD"],"gpt_icon":1},{"id":"2530982423","title":"Eli Lily Shares Down 1.4% Premarket After HSBC Double Downgrades Rating to 'Reduce'","url":"https://stock-news.laohu8.com/highlight/detail?id=2530982423","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530982423?lang=en_us&edition=fundamental","pubTime":"2025-04-28 16:37","pubTimestamp":1745829477,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250428:nL4N3R60MZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0203201768.USD","BK4599","BK4534","LU2237443895.HKD","LU2471134952.CNY","LU2237443465.HKD","LU2023250504.SGD","LU2211815571.USD","LU2357305700.SGD","LU0943347566.SGD","LU0385154629.USD","SG9999015986.USD","LU2468319806.SGD","LU1720051017.SGD","LU2552382132.HKD","LU1267930730.SGD","LU2750360641.GBP","LU0058720904.USD","LU2471134879.HKD","SG9999014914.USD","LU0094547139.USD","IE00BFTCPJ56.SGD","LU1868836757.USD","LU0820561909.HKD","LLY","LU0354030511.USD","LU0238689110.USD","LU1551013342.USD","LU1023059063.AUD","IE00BJT1NW94.SGD","LU1974910355.USD","LU1093756325.SGD","LU1988902786.USD","LU1989771016.USD","LU0096364046.USD","LU1868836914.USD","LU1280957306.USD","LU0820561818.USD","LU1720051108.HKD","LU0640476718.USD","SG9999001176.SGD","SGXZ31699556.SGD","LU2106854487.HKD","SGXZ57979304.SGD","LU0471298777.SGD","LU2461242641.AUD","IE00BK4W5L77.USD","LU2360106947.USD","LU2471134523.USD","LU0466842654.USD"],"gpt_icon":0},{"id":"2530414094","title":"Eli Lilly & Co  : HSBC Cuts to Reduce From Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2530414094","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530414094?lang=en_us&edition=fundamental","pubTime":"2025-04-28 13:21","pubTimestamp":1745817688,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250428:nAZN3R5MUG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2361044949.HKD","LU0882574139.USD","BK4534","LU1804176565.USD","IE00BK4W5L77.USD","BK4516","LU0456855351.SGD","LU1720051108.HKD","BK4585","LU2023250504.SGD","LU0417517546.SGD","LU1064131342.USD","LU2750360997.AUD","LU0289739699.SGD","LU1974910355.USD","LU2237443978.SGD","LU2112291526.USD","LU2552382058.USD","LLY","LU2211815571.USD","BK4599","LU2361045086.USD","LU1232071149.USD","IE00B2B36J28.USD","LU0354030511.USD","LU1366192091.USD","LU0094547139.USD","LU1551013342.USD","LU2089984988.USD","LU0689472784.USD","LU0466842654.USD","BK4007","LU0385154629.USD","LU1267930730.SGD","SG9999014914.USD","LU1291159041.SGD","LU2750360641.GBP","LU0203202063.USD","LU2237443895.HKD","LU2324357040.USD","LU0471298777.SGD","IE00B4R5TH58.HKD","LU0820561818.USD","IE00BJLML261.HKD","LU1868836914.USD","LU0256863811.USD","LU0823416689.USD","LU2237443549.SGD","SG9999015986.USD","LU2471134879.HKD"],"gpt_icon":0},{"id":"2530466960","title":"Pfizer announces Phase 3 CREST trial met primary endpoint of EFS","url":"https://stock-news.laohu8.com/highlight/detail?id=2530466960","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530466960?lang=en_us&edition=fundamental","pubTime":"2025-04-28 05:55","pubTimestamp":1745790914,"startTime":"0","endTime":"0","summary":"Pfizer (PFE) announced results from the pivotal Phase 3 CREST trial of sasanlimab, an investigational anti-PD-1 monoclonal antibody, in combination...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/pfizer-announces-phase-3-crest-trial-met-primary-endpoint-of-efs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/pfizer-announces-phase-3-crest-trial-met-primary-endpoint-of-efs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4534","BK4007","LU0289739699.SGD","LU0306806265.USD","IE00BBT3K403.USD","BK4568","LU0234572021.USD","LU0306807586.USD","LU1894683348.USD","IE00BLSP4452.SGD","IE00BLSP4239.USD","BK4581","IE0002270589.USD","BK4588","IE00B19Z3581.USD","IE00B19Z3B42.SGD","LU0058720904.USD","LU0225284248.USD","LU0868494617.USD","LU1023059063.AUD","LU1894683264.USD","BK4550","SG9999002224.SGD","SG9999003800.SGD","BK4585","LU0122379950.USD","BK4599","SG9999011175.SGD","IE000M9KFDE8.USD","LU0985481810.HKD","LU0170899867.USD","BK4533","LU1883839398.USD","LU1066051498.USD","SG9999001176.SGD","PFE","LU0456855351.SGD","SG9999013999.USD","BK4592","LU1066053197.SGD","LU0225771236.USD","LU0321505868.SGD","SGXZ57979304.SGD","SG9999002232.USD","LU1057294990.SGD","LU0321505439.SGD","SG9999001176.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":10,"totalSize":188,"code":"91000000","status":"200"}]}}